← Back to All Filings

GE HealthCare CEO Awarded Equity Compensation Package

Low SignificanceMarch 4, 2026 at 4:24:14 PM EST

GE HealthCare Technologies Inc.

$GEHC4CIK: 0001932393

Subscribe to track GEHC

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

GE HealthCare CEO Awarded Equity Compensation Package

Company: GE HealthCare Technologies Inc. (GEHC) Form: 4 | Filed: 2026-03-04 Significance: Low (Routine Compensation)

Insider: Arduini Peter J Title: President and CEO | Relationship: Director/Officer

Transaction: • Type: Grant (Award) • Security: Common Stock & Options • Shares: 49,120 (RSUs) + 129,140 (Options) • Price: $0.00 • Value: $0 (Compensation Grant) • Owned After: 255,255 (Direct Common Stock)

Key Insight: CEO Peter Arduini received his annual equity compensation consisting of RSUs and Stock Options vesting over 3 years. This is a routine retention award, not an open market purchase.

Market Context: Transaction represents <0.05% of shares outstanding. Neutral market impact expected.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: GE HealthCare Technologies Inc. (GEHC)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: CEO Peter Arduini received routine annual equity compensation (RSUs and Options) vesting over three years.
  • Market Impact: Neutral; standard executive compensation event.

Company Information

FieldValue
CompanyGE HealthCare Technologies Inc.
Ticker SymbolGEHC
CIK0001932393
Market Cap$38.41B

Insider Information

FieldValue
NameArduini Peter J
CIK0001323134
Title/PositionPresident and CEO
RelationshipDirector, Officer

Transaction Details

FieldValue
Form Type4
Transaction Date2026-03-02
Transaction CodeA (Grant/Award)
Security TypeCommon Stock (RSUs) & Options
Shares Involved49,120 (Stock) / 129,140 (Options)
Price Per Share$0.00
Total Value$0 (Compensation)
Shares Owned After255,255 (Common Stock)
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0 (Grant)
% of Market Cap0.00%
Shares Transacted178,260 (Combined)
% of Shares Outstanding0.039%
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: With a market cap of $38.41B, this compensation grant is standard for a CEO of a large-cap company.
  • Dilution Impact: The combined grant represents approximately 0.04% of the 455.75M shares outstanding, resulting in negligible dilution.
  • Transaction Significance: This is a Code "A" transaction (Grant), indicating compensation rather than an investment decision by the insider. It does not signal specific bullish sentiment like an open-market purchase would.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: Routine compensation grants are expected operational events and do not typically drive stock price movement.

Volume & Sentiment

  • Expected Volume Impact: None.
  • Sentiment Indicator: Neutral.

Additional Context

Transaction Notes

  • Vesting Terms: Both the RSUs and Options vest in three installments (33%, 33%, 34%) starting September 2, 2027. This structure focuses on long-term retention.
  • Option Details: The 129,140 options have an exercise price of $80.16 and expire in 2036.
Topics:#GEHC#GEHealthCare#Form4#ExecutiveCompensation#StockGrant#CEO#InsiderActivity#MarketNews

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.